555
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Integrating social and biomedical science in HIV vaccine research: obstacles, opportunities and ways forward

Pages 1-3 | Published online: 09 Jan 2014

References

  • Newman PA. Towards a science of community engagement. Lancet367(9507), 302 (2006).
  • Fuchs JD, Sobieszczyk ME, Hammer SM, Buchbinder SP. Lessons drawn from recent HIV vaccine efficacy trials. J. Acquir. Immune Defic. Syndr.55(Suppl. 2), S128–S131 (2010).
  • Lau CY, Stansbury JP, Gust DA, Kafaar Z. Social and behavioral science in HIV vaccine trials; a gap assessment of literature. Expert Rev. Vaccines8(2), 179–190 (2009).
  • Singh JA, Mill EJ. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong? PLoS Med.2(9), e234 (2005).
  • Newman PA, Yim S, Daley A et al. “Once bitten, twice shy”: participant perspectives in the aftermath of an early HIV vaccine trial termination. Vaccine29, 451–458 (2011).
  • Newman PA, Logie C, James L et al. “Speaking the dialect”: understanding public discourse in the aftermath of an HIV vaccine trial shutdown. Am. J. Pub. Health101(9), 1749–1758 (2011).
  • Buchbinder SP, Mehrotra DV, Duerr A et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebo-controlled, test-of-concept trial. Lancet372(9653), 1881–1893 (2008).
  • Rerks-Ngarm S, Pitisutthithum P, Nitayaphan S et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med.361(23), 2209–2220 (2009).
  • Gust DA, Wiegand RE, Para M, Chen RT, Bartholow BN. HIV testing outside of the study among men who have sex with men participating in an HIV vaccine efficacy trial. J. Acquir. Immu. Defic. Syndr.52(2), 294–298 (2009).
  • Institute of Medicine. Calling the shots: immunization finance policies and practices. National Academies Press, Washington, DC, USA (2000).
  • Newman PA, Logie C. HIV vaccine acceptability: a systematic review and meta-analysis. AIDS24(11), 1749–1756 (2010).
  • Woolf SH. The meaning of translational research and why it matters. JAMA299(2), 211–213 (2008).
  • Streefland PH. Introduction of a HIV vaccine in developing countries: social and cultural dimensions. Vaccine21, 1304–1309 (2003).
  • Newman PA, Seiden DS, Roberts KJ, Kakinami L, Duan N. A small dose of HIV? HIV vaccine mental models and risk communication. Health Educ. Behav.36(2), 321–333 (2009).
  • Montgomery C, Pool R. Critically engaging: integrating the social and the biomedical in international microbicides research. J. Int. AIDS Soc.14(Suppl. 2), S4 (2011).
  • Newman PA, Duan N, Kakinami L, Roberts K. What can HIV vaccine trials teach about dissemination? Vaccine26(20), 2528–2536 (2008).
  • Lindegger G, Millford C, Slack C, Quayle M, Xaba X, Vards E. Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J. Acquir. Immu. Defic. Syndr.43(5), 560–566 (2006).
  • Swartz L, Kagee A. Community participation in AIDS vaccine trials: empowerment or science? Soc. Sci. Med.63, 1143–1146 (2006).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.